Filing Details

Accession Number:
0001209191-14-011880
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-19 17:08:42
Reporting Period:
2014-01-11
Filing Date:
2014-02-19
Accepted Time:
2014-02-19 17:08:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131096 Athenahealth Inc ATHN Services-Business Services, Nec (7389) 043387530
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298669 M Timothy Adams 311 Arsenal Street
Watertown MA 02472
Cfo & Svp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-01-11 3,692 $135.68 40,327 No 4 F Direct
Common Stock Acquisiton 2014-02-18 30,000 $40.90 70,327 No 4 M Direct
Common Stock Disposition 2014-02-18 5,253 $192.06 65,074 No 4 S Direct
Common Stock Disposition 2014-02-18 8,797 $193.09 56,277 No 4 S Direct
Common Stock Disposition 2014-02-18 2,694 $194.10 53,583 No 4 S Direct
Common Stock Disposition 2014-02-18 3,256 $195.21 50,327 No 4 S Direct
Common Stock Disposition 2014-02-18 5,562 $196.58 44,765 No 4 S Direct
Common Stock Disposition 2014-02-18 4,438 $197.85 40,327 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-02-18 30,000 $0.00 30,000 $40.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2011-01-11 2020-02-01 No 4 M Direct
Footnotes
  1. These shares were withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the Reporting Person on February 1, 2010. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
  2. The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on December 17, 2013, in accordance with Rule 10b5-1.
  3. This price represents the weighted average of sales ranging from $191.59 to $192.50. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  4. This price represents the weighted average of sales ranging from $192.68 to $193.65. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  5. This price represents the weighted average of sales ranging from $193.69 to $194.50. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  6. This price represents the weighted average of sales ranging from $195.00 to $195.60. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  7. This price represents the weighted average of sales ranging from $196.09 to $197.00. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  8. This price represents the weighted average of sales ranging from $197.39 to $198.00. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.